Safety profile of inactivated COVID-19 vaccine in indonesian adults.

ABSTRACT:

Background

Vaccines are urgently needed to handle the morbidity and mortality of the COVID-19 pandemic in Indonesia. The inactivated vaccine is widely used in Indonesia's national immunization program due to its eligibility of stock, easier to transport, and considered to be more established than newer platforms. In this study, we aimed to evaluate the safety profile of the inactivated vaccine and analyze the safety profile between adults and the elderly.

Methods

A prospective analytical study was conducted to evaluate the safety profile of inactivated COVID-19 vaccine among healthy adults aged ≥ 18 years from September 2nd to December 28th, 2021, at ten primary health centers from 5 districts in Jakarta, Indonesia. The participants were instructed to record the symptoms aft

SUBMITTER: Satari HI 

PROVIDER: S-EPMC10257516 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature